Comprehensive integrative profiling of upper tract urothelial carcinomas von Su, Xiaoping, Lu, Xiaofan, Bazai, Sehrish Khan, Comperat, Eva, Mouawad, Roger, Yao, Hui, Roupret, Morgan, Spano, Jean-Philippe, Khayat, David, Davidson, Irwin, Tannir, Nizar N., Yan, Fangrong, Malouf, Gabriel G.

Volltext

Additional file 1 of Comprehensive integrative profiling of upper tract urothelial carcinomas von Su, Xiaoping, Lu, Xiaofan, Bazai, Sehrish Khan, Compérat, Eva, Mouawad, Roger, Yao, Hui, Rouprêt, Morgan, Spano, Jean-Philippe, Khayat, David, Davidson, Irwin, Tannir, Nizar N., Yan, Fangrong, Malouf, Gabriel G.

Volltext bestellen

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma von Motzer, Robert J, Tannir, Nizar M, McDermott, David F, Arén Frontera, Osvaldo, Melichar, Bohuslav, Choueiri, Toni K, Plimack, Elizabeth R, Barthélémy, Philippe, Porta, Camillo, George, Saby, Powles, Thomas, Donskov, Frede, Neiman, Victoria, Kollmannsberger, Christian K, Salman, Pamela, Gurney, Howard, Hawkins, Robert, Ravaud, Alain, Grimm, Marc-Oliver, Bracarda, Sergio, Barrios, Carlos H, Tomita, Yoshihiko, Castellano, Daniel, Rini, Brian I, Chen, Allen C, Mekan, Sabeen, McHenry, M. Brent, Wind-Rotolo, Megan, Doan, Justin, Sharma, Padmanee, Hammers, Hans J, Escudier, Bernard

Volltext

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma von Choueiri, Toni K, Escudier, Bernard, Powles, Thomas, Mainwaring, Paul N, Rini, Brian I, Donskov, Frede, Hammers, Hans, Hutson, Thomas E, Lee, Jae-Lyun, Peltola, Katriina, Roth, Bruce J, Bjarnason, Georg A, Géczi, Lajos, Keam, Bhumsuk, Maroto, Pablo, Heng, Daniel Y.C, Schmidinger, Manuela, Kantoff, Philip W, Borgman-Hagey, Anne, Hessel, Colin, Scheffold, Christian, Schwab, Gisela M, Tannir, Nizar M, Motzer, Robert J

Volltext

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial von Choueiri, Toni K, Dr, Escudier, Bernard, MD, Powles, Thomas, Prof, Tannir, Nizar M, Prof, Mainwaring, Paul N, MD, Rini, Brian I, Prof, Hammers, Hans J, MD, Donskov, Frede, MD, Roth, Bruce J, Prof, Peltola, Katriina, MD, Lee, Jae Lyun, Prof, Heng, Daniel Y C, MD, Schmidinger, Manuela, Prof, Agarwal, Neeraj, MD, Sternberg, Cora N, Prof, McDermott, David F, MD, Aftab, Dana T, PhD, Hessel, Colin, MS, Scheffold, Christian, MD, Schwab, Gisela, MD, Hutson, Thomas E, Prof, Pal, Sumanta, MD, Motzer, Robert J, Prof

Volltext

Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence von Bishop, Andrew J., MD, Tao, Randa, MD, Rebueno, Neal C., CMS, Christensen, Eva N., MD, PhD, Allen, Pamela K., PhD, Wang, Xin A., PhD, Amini, Behrang, MD, PhD, Tannir, Nizar M., MD, Tatsui, Claudio E., MD, Rhines, Laurence D., MD, Li, Jing, MD, PhD, Chang, Eric L., MD, Brown, Paul D., MD, Ghia, Amol J., MD

Volltext

Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma von Msaouel, Pavlos, Malouf, Gabriel G., Su, Xiaoping, Yao, Hui, Tripathi, Durga N., Soeung, Melinda, Gao, Jianjun, Rao, Priya, Coarfa, Cristian, Creighton, Chad J., Bertocchio, Jean-Philippe, Kunnimalaiyaan, Selvi, Multani, Asha S., Blando, Jorge, He, Rong, Shapiro, Daniel D., Perelli, Luigi, Srinivasan, Sanjana, Carbone, Federica, Pilié, Patrick G., Karki, Menuka, Seervai, Riyad N.H., Vokshi, Bujamin H., Lopez-Terrada, Dolores, Cheng, Emily H., Tang, Ximing, Lu, Wei, Wistuba, Ignacio I., Thompson, Timothy C., Davidson, Irwin, Giuliani, Virginia, Schlacher, Katharina, Carugo, Alessandro, Heffernan, Timothy P., Sharma, Padmanee, Karam, Jose A., Wood, Christopher G., Walker, Cheryl L., Genovese, Giannicola, Tannir, Nizar M.

Volltext

Landscape of DNA Virus Associations across Human Malignant Cancers: Analysis of 3,775 Cases Using RNA-Seq von Khoury, Joseph D, Tannir, Nizar M, Williams, Michelle D, Chen, Yunxin, Yao, Hui, Zhang, Jianping, Thompson, Erika J, Meric-Bernstam, Funda, Medeiros, L Jeffrey, Weinstein, John N, Su, Xiaoping

Volltext

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma von Zhou, L, Liu, X-D, Sun, M, Zhang, X, German, P, Bai, S, Ding, Z, Tannir, N, Wood, C G, Matin, S F, Karam, J A, Tamboli, P, Sircar, K, Rao, P, Rankin, E B, Laird, D A, Hoang, A G, Walker, C L, Giaccia, A J, Jonasch, E

Volltext

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy von Kim, Sang T., Chu, Yanshuo, Misoi, Mercy, Suarez-Almazor, Maria E., Tayar, Jean H., Lu, Huifang, Buni, Maryam, Kramer, Jordan, Rodriguez, Emma, Hussain, Zulekha, Neelapu, Sattva S., Wang, Jennifer, Shah, Amishi Y., Tannir, Nizar M., Campbell, Matthew T., Gibbons, Don L., Cascone, Tina, Lu, Charles, Blumenschein, George R., Altan, Mehmet, Lim, Bora, Valero, Vincente, Loghin, Monica E., Tu, Janet, Westin, Shannon N., Naing, Aung, Garcia-Manero, Guillermo, Abdel-Wahab, Noha, Tawbi, Hussein A., Hwu, Patrick, Oliva, Isabella C. Glitza, Davies, Michael A., Patel, Sapna P., Zou, Jun, Futreal, Andrew, Diab, Adi, Wang, Linghua, Nurieva, Roza

Volltext

Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02) von Diab, Adi, Tannir, Nizar M., Bentebibel, Salah-Eddine, Hwu, Patrick, Papadimitrakopoulou, Vassiliki, Haymaker, Cara, Kluger, Harriet M., Gettinger, Scott N., Sznol, Mario, Tykodi, Scott S., Curti, Brendan D., Tagliaferri, Mary A., Zalevsky, Jonathan, Hannah, Alison L., Hoch, Ute, Aung, Sandra, Fanton, Christie, Rizwan, Ahsan, Iacucci, Ernesto, Liao, Yijie, Bernatchez, Chantale, Hurwitz, Michael E., Cho, Daniel C.

Volltext

p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors von Carugo, Alessandro, Minelli, Rosalba, Sapio, Luigi, Soeung, Melinda, Carbone, Federica, Robinson, Frederick S., Tepper, James, Chen, Ziheng, Lovisa, Sara, Svelto, Maria, Amin, Samirkumar, Srinivasan, Sanjana, Del Poggetto, Edoardo, Loponte, Sara, Puca, Francesca, Dey, Prasenjit, Malouf, Gabriel G., Su, Xiaoping, Li, Liren, Lopez-Terrada, Dolores, Rakheja, Dinesh, Lazar, Alexander J., Netto, George J., Rao, Priya, Sgambato, Alessandro, Maitra, Anirban, Tripathi, Durga N., Walker, Cheryl L., Karam, Jose A., Heffernan, Timothy P., Viale, Andrea, Roberts, Charles W.M., Msaouel, Pavlos, Tannir, Nizar M., Draetta, Giulio F., Genovese, Giannicola

Volltext

VirusSeq: software to identify viruses and their integration sites using next-generation sequencing of human cancer tissue von Chen, Yunxin, Yao, Hui, Thompson, Erika J, Tannir, Nizar M, Weinstein, John N, Su, Xiaoping

Volltext

NSD1 Inactivation and SETD2 Mutation Drive a Convergence toward Loss of Function of H3K36 Writers in Clear Cell Renal Cell Carcinomas von Su, Xiaoping, Zhang, Jianping, Mouawad, Roger, Compérat, Eva, Rouprêt, Morgan, Allanic, Frederick, Parra, Jérôme, Bitker, Marc-Olivier, Thompson, Erika J, Gowrishankar, Banumathy, Houldsworth, Jane, Weinstein, John N, Tost, Jorg, Broom, Bradley M, Khayat, David, Spano, Jean-Philippe, Tannir, Nizar M, Malouf, Gabriel G

Volltext

Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy von Kim, Sang T., Chu, Yanshuo, Misoi, Mercy, Suarez-Almazor, Maria E., Tayar, Jean H., Lu, Huifang, Buni, Maryam, Kramer, Jordan, Rodriguez, Emma, Hussain, Zulekha, Neelapu, Sattva S., Wang, Jennifer, Shah, Amishi Y., Tannir, Nizar M., Campbell, Matthew T., Gibbons, Don L., Cascone, Tina, Lu, Charles, Blumenschein, George R., Altan, Mehmet, Lim, Bora, Valero, Vincente, Loghin, Monica E., Tu, Janet, Westin, Shannon N., Naing, Aung, Garcia-Manero, Guillermo, Abdel-Wahab, Noha, Tawbi, Hussein A., Hwu, Patrick, Oliva, Isabella C. Glitza, Davies, Michael A., Patel, Sapna P., Zou, Jun, Futreal, Andrew, Diab, Adi, Wang, Linghua, Nurieva, Roza

Volltext

Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders von Boilève, A, Carlo, M I, Barthélémy, P, Oudard, S, Borchiellini, D, Voss, M H, George, S, Chevreau, C, Landman-Parker, J, Tabone, M-D, Chism, D D, Amin, A, Bilen, M A, Bosse, D, Coulomb-L'hermine, A, Su, Xiaoping, Choueiri, T K, Tannir, Nizar M, Malouf, Gabriel G

Volltext

Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis von Liu, X-D, Yao, J, Tripathi, D N, Ding, Z, Xu, Y, Sun, M, Zhang, J, Bai, S, German, P, Hoang, A, Zhou, L, Jonasch, D, Zhang, X, Conti, C J, Efstathiou, E, Tannir, N M, Eissa, N T, Mills, G B, Walker, C L, Jonasch, E

Volltext

Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma von Jonasch, Eric, Slack, Rebecca S, Geynisman, Daniel M, Hasanov, Elshad, Milowsky, Matthew I, Rathmell, W Kimryn, Stovall, Summer, Juarez, Donna, Gilchrist, Troy R, Pruitt, Lisa, Ornstein, Moshe C, Plimack, Elizabeth R, Tannir, Nizar M, Rini, Brian I

Volltext

Characterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencing von Malouf, Gabriel G., Zhang, Jianping, Yuan, Ying, Compérat, Eva, Rouprêt, Morgan, Cussenot, Olivier, Chen, Yunxin, Thompson, Erika J., Tannir, Nizar M., Weinstein, John N., Valero, Vicente, Khayat, David, Spano, Jean-Philippe, Su, Xiaoping

Volltext

Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial von Cella, David, Escudier, Bernard, Tannir, Nizar M, Powles, Thomas, Donskov, Frede, Peltola, Katriina, Schmidinger, Manuela, Heng, Daniel Y C, Mainwaring, Paul N, Hammers, Hans J, Lee, Jae Lyun, Roth, Bruce J, Marteau, Florence, Williams, Paul, Baer, John, Mangeshkar, Milan, Scheffold, Christian, Hutson, Thomas E, Pal, Sumanta, Motzer, Robert J, Choueiri, Toni K

Volltext